Bernstein Haroldinsider trades
In SEC Form 4 filings, Bernstein Harold is listed as President, R&D & CMO of Maze Therapeutics, Inc. (MAZE). In the last 90 days, Bernstein Harold sold $1.38M of Maze Therapeutics, Inc. (MAZE) on the open market and bought none. 3 of the 7 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| MAZEMaze Therapeutics, Inc. | President, R&D & CMO | 13 | Oct 2 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| MAZEMaze Therapeutics, Inc. | Oct 1 | Oct 2 | M | 16,141 | $10.42 | $168,189 | 16,141 | Yes | Form 4 |
| MAZEMaze Therapeutics, Inc. | Oct 1 | Oct 2 | S | 16,141 | $26.93 | Sale −$434,743 | not reported | Yes | Form 4 |
| MAZEMaze Therapeutics, Inc. | Oct 1 | Oct 2 | M · derivative | 16,141 | $10.42 | $168,189 | 144,521 | Yes | Form 4 |
| MAZEMaze Therapeutics, Inc. | Sep 4 | Sep 8 | S | 9,705 | $26.22 | Sale −$254,502 | not reported | Yes | Form 4 |
| MAZEMaze Therapeutics, Inc. | Sep 3 | Sep 4 | S | 5,130 | $26.01 | Sale −$133,448 | 9,764 | No | Form 4 |
| MAZEMaze Therapeutics, Inc. | Sep 3 | Sep 4 | S | 59 | $25.78 | Sale −$1,521 | 9,705 | No | Form 4 |
| MAZEMaze Therapeutics, Inc. | Sep 2 | Sep 4 | S | 4,481 | $26.38 | Sale −$118,191 | 15,519 | No | Form 4 |
| MAZEMaze Therapeutics, Inc. | Sep 2 | Sep 4 | S | 625 | $27.12 | Sale −$16,951 | 14,894 | No | Form 4 |
| MAZEMaze Therapeutics, Inc. | Sep 1 | Sep 3 | M | 16,141 | $10.42 | $168,189 | 16,141 | Yes | Form 4 |
| MAZEMaze Therapeutics, Inc. | Sep 1 | Sep 3 | S | 16,141 | $26.36 | Sale −$425,512 | not reported | Yes | Form 4 |
| MAZEMaze Therapeutics, Inc. | Sep 1 | Sep 3 | M | 20,000 | $0.00 | $0 | 20,000 | Yes | Form 4 |
| MAZEMaze Therapeutics, Inc. | Sep 1 | Sep 3 | M · derivative | 16,141 | $10.42 | $168,189 | 160,662 | Yes | Form 4 |
| MAZEMaze Therapeutics, Inc. | Sep 1 | Sep 3 | M · derivative | 20,000 | $0.00 | $0 | 20,000 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.